Medical device manufacturing operates under a documentation and quality burden that makes every process variable a potential audit finding. Each material lot must be traced. Each critical process step must be controlled and verified. Each deviation must be investigated. In this environment, process complexity is not just a production concern — it’s a compliance risk. One-part epoxy reduces process complexity at the adhesive joining step, and in doing so, reduces the compliance surface area that comes with managing a two-component system.
Why Mixing Complexity Creates Quality System Risk
In a regulated medical device production environment, every process parameter that affects product quality must be identified, controlled, and monitored. For a two-part epoxy, mix ratio is a critical process parameter. It requires defined controls: calibrated meter-mix equipment with documented maintenance intervals, operator qualification for manual mixing, in-process checks for mix ratio accuracy, and procedures for handling off-ratio events including material rejection, equipment investigation, and nonconformance documentation.
Every one of those control elements is a potential failure point. A meter-mix pump that drifts between calibration checks may produce off-ratio material for an extended period. An operator not following the mixing procedure — even a well-trained one under time pressure — introduces variability. The in-process check catches some failures but not all. Each missed failure that reaches the product is a potential CAPA event.
One-part epoxy has no mix ratio. The formulation is established at the manufacturer’s facility and verified before shipment. The mix ratio control elements are replaced with incoming material acceptance criteria: verify lot certification, verify shelf life, verify storage compliance. These checks are simpler to execute, simpler to document, and simpler to audit.
Biocompatibility and Regulatory Compliance
Medical device adhesives must meet biocompatibility requirements appropriate to the device’s intended use and patient contact classification. ISO 10993 is the primary standard framework — it specifies which biocompatibility tests are applicable based on the nature and duration of contact with the body or body fluids.
Many one-part epoxy formulations used in medical device assembly have been tested and characterized to ISO 10993 requirements, covering cytotoxicity, sensitization, and irritation as a baseline. For devices with more extensive patient contact, additional testing — systemic toxicity, hemocompatibility, implantation response — may be required depending on the risk classification. Manufacturer testing data and certificates of compliance to ISO 10993 should be obtained and reviewed during adhesive qualification.
Unlike some two-part systems where the uncured components may include sensitizing or reactive amines in the hardener, one-part epoxy systems can be selected to minimize residual reactive chemistry in the cured state. Fully cured material is generally more chemically stable and less likely to contain extractable reactive species than systems cured at ambient temperature with active amine hardeners.
If you’re at the adhesive qualification stage for a medical device program and need biocompatibility documentation or formulation guidance, Email Us — Incure can provide technical support and available compliance documentation.
Cure Process Verifiability
Regulated manufacturing requires that critical processes be verified, not just performed. For an adhesive cure step, verification means confirming that the assembly experienced the correct cure cycle — temperature, time, and ramp profile — in a documented, traceable way.
Thermal cure of a one-part epoxy is inherently verifiable. Oven chart recorders or data loggers capture the temperature profile of each cure load and produce a permanent record that can be referenced in the device history record. The cure cycle is a single, defined operation with clear pass/fail criteria. If the oven temperature dropped during the cycle, the record shows it, and the disposition of the affected load can be documented and justified.
Room-temperature cure systems are harder to verify. Ambient temperature, relative humidity, and actual cure time can all vary without detection, and the cure profile cannot be reconstructed from the production record with the same fidelity as a thermal cure log. For facilities under ISO 13485 or FDA 21 CFR Part 820 quality systems, the verification advantage of heat cure is a meaningful compliance benefit.
Device Categories Well-Suited to One-Part Epoxy
One-part epoxy is used in medical device assembly across a wide range of device types. Surgical instrument handles and endoscopic device components require bonds that withstand repeated steam sterilization cycles; one-part epoxy grades with high Tg and good chemical resistance to autoclave conditions are available for these applications.
Electronic medical devices — monitors, implantable electronic subassemblies, diagnostic equipment — use one-part epoxy for component fixation, PCB potting, and connector sealing. Catheter tip and shaft assemblies use small-format syringe dispensing of low-viscosity one-part epoxy for precise, contained bond deposits.
Diagnostic disposables — cartridges, cassettes, microfluidic devices — often incorporate bonded polymer substrates where dimensional accuracy and bond consistency directly affect assay performance. One-part epoxy’s stable viscosity and precise cure cycle support the bond line control required for these applications.
Traceability and Change Control
Lot traceability in medical device manufacturing must link every material to every finished unit. One-part epoxy simplifies this linkage: one lot number per adhesive application, one entry in the device history record. Two-part systems require tracking two component lot numbers and the mix date and conditions for each batch — a more complex documentation trail with more opportunities for gaps.
Material changes — switching to a new lot, a new formulation, or a new supplier — require change control review. One-part epoxy changes are generally lower complexity from a change control standpoint because the single-component chemistry has fewer interacting variables. A new lot of the same formulation can be qualified through a simplified incoming test protocol rather than a full re-characterization, provided the manufacturer’s certificate of conformance documents equivalence to the previous lot.
Contact Our Team to discuss one-part epoxy qualification for your medical device assembly application.
Visit www.incurelab.com for more information.